Update on cardiac stem cell therapy in heart failure

Current Opinion in Cardiology

Volumn 27, Issue 2, 2012, Pages 154-160

  Donndorf, Peter ^a   Strauer, Bodo Eckehard ^a   Steinhoff, Gustav ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

heart failure; ischaemic; stem cell; trial

Indexed keywords

PLACEBO;

CARDIAC STEM CELL THERAPY; CELL POPULATION; CELL TYPE; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); CORONARY ARTERY BYPASS GRAFT; HEART FAILURE; HUMAN; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; REVASCULARIZATION; REVIEW; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

HEART FAILURE; HUMANS; MYOCARDIAL ISCHEMIA; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84857061599     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32834fe969     Document Type: Review

References (39)

1. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infracted myocardium. Nature 2001; 410:701-705. (Pubitemid 32290358)
2. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001; 107:1395-1402. (Pubitemid 32522033)
3. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009; 324:98-102.
4. Strauer BE, Steinhoff G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol 2011; 58:1095-1104.
5. Freyman T, Polin G, Osman H, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006; 27:1114-1122.
6. Menasche P. Cardiac cell therapy: lessons from clinical trials. J Mol Cell Cardiol 2011; 50:258-265.
7. Larose E, Proulx G, Voisine P, et al. Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: An in vivo cardiovascular magnetic resonance study. Catheter Cardiovasc Interv 2010; 75:120-127.
8. Yeo C, Mathur A. Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial. Regen Med 2009; 4:119-127.
9. Hu S, Liu S, Zheng Z, et al. Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: A singlecenter, randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 2011; 57:2409-2415.
10. Ang KL, Shenje LT, Srinivasan L, Galinanes M. Repair of the damaged heart by bone marrow cells: from experimental evidence to clinical hope. Ann Thorac Surg 2006; 82:1549-1558. (Pubitemid 44402357)
11. Bai Y, Sun T, Ye P. Age, gender and diabetic status are associated with effects of bone marrowcell therapy on recovery of left ventricular function after acute myocardial infarction: A systematic review and meta-analysis. Ageing Res Rev 2010; 9:418-423.
12. Donndorf P, Kundt G, Kaminski A, et al. Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: A meta-analysis. J Thorac Cardiovasc Surg 2011; 142:911-920.
13. Wen Y, Meng L, Xie J, Ouyang J. Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: A meta-analysis. Expert Opin Biol Ther 2011; 11:559-567.
14. + bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007; 133:717-725.
15. Menasche P, Alfieri O, Janssens S, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008; 117:1189-1200. (Pubitemid 351552018)
16. Perin EC, Silva GV, Henry TD, et al. A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J 2011; 161:1078-1087.
17. Trachtenberg B, Velazquez DL, Williams AR, et al. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy. Am Heart J 2011; 161:487-493.
18. Mocini D, Staibano M, Mele L, et al. Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting. Am Heart J 2006; 151:192-197. (Pubitemid 41815354)
19. Hendrikx M, Hensen K, Clijsters C, et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: Results from a randomized controlled clinical trial. Circulation 2006; 114:I101-107. (Pubitemid 44297136)
20. Strauer BE, Brehm M, Zeus T, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: The IACT Study. J Am Coll Cardiol 2005; 46:1651-1658. (Pubitemid 41531618)
21. Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006; 355:1222-1232. (Pubitemid 44427446)
22. Strauer BE, Yousef M, Schannwell CM. The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heart failure: The STAR-heart study. Eur J Heart Fail 2010; 12:721-729.
23. Choi YH, Kurtz A, Stamm C. Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther 2011; 22:3-17.
24. Duffy GP, D'Arcy S, Ahsan T, et al. Mesenchymal stem cells overexpressing ephrin-b2 rapidly adopt an early endothelial phenotype with simultaneous reduction of osteogenic potential. Tissue Eng Part A 2010; 16:2755-2768.
25. Martino HF, Oliveira PS, Souza FC, et al. A safety and feasibility study of cell therapy in dilated cardiomyopathy. Braz J Med Biol Res 2010; 43:989-995.
26. Strauer BE, Brehm M, Schannwell CM. The therapeutic potential of stem cells in heart disease. Cell Prolif 2008; 41 (Suppl 1):126-145. (Pubitemid 350295849)
27. Abraham MR, Henrikson CA, Tung L, et al. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res 2005; 97:159-67. (Pubitemid 41033472)
28. Kim SK, Pak HN, Park JH, et al. Cardiac cell therapy with mesenchymal stem cell induces cardiac nerve sprouting, angiogenesis, and reduced connexin43- positive gap junctions, but concomitant electrical pacing increases connexin43- positive gap junctions in canine heart. Cardiol Young 2010; 20:308-317.
29. Fukushima S, Coppen SR, Lee J, et al. Choice of cell-delivery route for skeletal myoblast transplantation for treating postinfarction chronic heart failure in rat. PLoS One 2008; 3:e3071.
30. Veltman CE, Soliman OI, Geleijnse ML, et al. Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy. Eur Heart J 2008; 29:1386-1396.
31. Chen HS, Kim C, Mercola M. Electrophysiological challenges of cell-based myocardial repair. Circulation 2009; 120:2496-2508.
32. Assmus B, Tonn T, Seeger FH, et al. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy. J Am Coll Cardiol 2010; 55:1385-1394.
33. Prokopi M, Pula G, Mayr U, et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 2009; 114:723-732.
34. Horst KW. Stem cell therapy for myocardial infarction: Are we missing time? Cardiology 2010; 117:1-10.
35. Cheng K, Li TS, Malliaras K, et al. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 2010; 106:1570-1581.
36. Ghadge SK, Muhlstedt S, Ozcelik C, Bader M. SDF-1alpha as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol Ther 2011; 129:97-108.
37. Penn MS. SDF-1:CXCR4 axis is fundamental for tissue preservation and repair. Am J Pathol 2010; 177:2166-2168.
38. Haider H, Ashraf M. Preconditioning and stem cell survival. J Cardiovasc Transl Res 2010; 3:89-102.
39. Lau JF, Anderson SA, Adler E, Frank JA. Imaging approaches for the study of cell-based cardiac therapies. Nat Rev Cardiol 2010; 7:97-105.